Convalescent Plasma Improves Survival in COVID Patients With ARDS, New Trial Shows

(MedPage Today) -- Convalescent plasma reduced mortality in COVID-19 patients with acute respiratory distress syndrome (ARDS) when provided within 5 days of invasive mechanical ventilation, the randomized open-label CONFIDENT trial showed. Mortality...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news